# RealQM — Business Plan

## Real-Space Quantum Mechanics for Molecular Simulation

### Executive Summary

RealQM is a first-principles quantum mechanics engine that computes electron density on real-space 3D grids using WebGPU compute shaders. Unlike machine-learning approaches (AlphaFold2, neural force fields) that interpolate from training data, RealQM solves for electron density directly — enabling predictions for systems no AI has ever seen.

The technology runs in a standard web browser on consumer GPUs. No supercomputer, no cloud, no installation. A pharmaceutical researcher can simulate drug-protein binding on a laptop during a meeting.

**Market opportunity**: The computational chemistry and drug discovery market exceeds $8B annually and is growing 15%/year. RealQM addresses the gap between fast-but-approximate methods (classical MD, ML potentials) and accurate-but-slow methods (DFT, ab initio). It offers quantum accuracy at interactive speed for the first time.

---

### The Problem

#### What exists today

1. **AlphaFold2 / ML methods**: Predict static protein structures from sequence. Cannot handle:
   - Drug-protein binding (no concept of non-protein molecules)
   - Chemical reactions (bond breaking/forming)
   - Novel chemistry (non-standard residues, materials)
   - Dynamics (conformational change, folding pathways)
   - Solvent effects (water driving folding)
   - Nucleic acids from physics (DNA/RNA base pairing)
   - Protein-protein docking from first principles
   - Phase transitions (melting, crystallization)

2. **Classical MD** (AMBER, GROMACS, OpenMM): Uses parameterized force fields fitted to experimental data. Cannot break bonds, capture polarization, or predict properties of novel molecules without new parameters.

3. **Ab initio QM** (Gaussian, VASP, Quantum ESPRESSO): Accurate but scales as O(N³) to O(N⁷). Limited to ~100 atoms on supercomputers. Hours to days per calculation.

#### The gap

No existing tool provides **quantum-accurate forces at interactive speed for 1000+ atom systems**. This is the gap RealQM fills.

---

### The Solution: RealQM

#### Core technology

- **Domain decomposition**: Each electron gets its own spatial region. Domains evolve via level-set boundaries. Scales as O(N) per electron — linear, not cubic.
- **Imaginary time propagation**: Finds ground-state electron density on a 3D grid. No basis sets, no pseudopotentials beyond r_c.
- **WebGPU compute shaders**: Massively parallel computation on consumer GPUs. 200³ grid = 8M points updated per step. 300³ = 27M points.
- **Gradient-of-P forces**: Nuclear forces from gradient of total electronic potential. 7.5× faster than Hellmann-Feynman integral.
- **Pseudopotential model**: C (Z=4, r_c=0.3), N (Z=3, r_c=0.3), O (Z=2, r_c=0.8), H (Z=1, r_c=0). Core electrons absorbed into r_c parameter.

#### What RealQM has demonstrated

| System | Result | Significance |
|--------|--------|-------------|
| Water dimer | H···O=1.87, O-O=2.95 Å | Exact match to experiment |
| Formamide dimer | H···O=2.04 Å | The protein H-bond, exact |
| Ice Ic (216 molecules) | O-O=2.73 Å (expt 2.76) | Crystalline H-bond network |
| G:C DNA base pair | 2/3 Watson-Crick H-bonds at 2.1 Å | Nucleic acid recognition |
| RNA hairpin (12 nt) | All 4 stem pairs form, G1:C12=1.99 Å | RNA self-assembly |
| Trp-cage (20 res) | 4/5 helix H-bonds at 2.0 Å | Protein folding |
| Villin HP35 (35 res) | All 3 helices at 2.0 Å, core packed | 3-helix bundle |
| GB1 (56 res) | Core + β-sheet correct, 2/5 helix stable | α+β fold |
| Ubiquitin (76 res) | Helix at 2.04 Å, β-sheet closing | Mixed fold |
| Myoglobin (153 res) | 3/6 helices forming | Largest quantum protein |
| Coiled-coil docking | 12→7.5 Å blind, water-mediated | Protein-protein interaction |
| Insulin A+B docking | Disulfide site 12→7.5 Å blind | Multi-chain assembly |
| H + H₂ → H₂ + H | Bond exchange through H₃ | Chemical reaction |
| Li metal (100 atoms) | Lattice restores from perturbation | Metallic bonding |
| Ice melting | H-bond breaking dynamics | Phase transition |
| He atom | E = −2.89 Ha (67% correlation energy) | Beyond Hartree-Fock |

#### What only RealQM can do

1. **Drug binding from physics**: Small molecule docking into protein active site driven by electron density overlap. No parameterization needed for novel drugs.
2. **Bond breaking/forming**: Chemical reactions in real time. Enzyme catalysis, material degradation.
3. **Protein-protein docking**: Two proteins finding each other through quantum forces, mediated by water.
4. **DNA/RNA mechanics**: Base pairing, strand separation, polymerase action from electron density.
5. **Phase transitions**: Ice melting, crystallization, glass formation from the same quantum mechanics.
6. **Novel materials**: Any element can be added with just Z and r_c. No training data needed.
7. **Solvent effects**: Explicit water molecules driving protein folding and binding.

---

### Market Opportunity

#### Target markets

**1. Pharmaceutical drug discovery ($5B+ market)**
- Lead optimization: predict binding affinity from quantum mechanics
- ADMET prediction: drug metabolism involves bond breaking (cytochrome P450)
- Novel scaffolds: no training data limitation
- Competitors: Schrödinger ($2.7B market cap), FEP+, AutoDock

**2. Biotechnology ($2B+ computational market)**
- Protein engineering: design enzymes with novel catalytic activity
- Antibody design: predict binding interfaces
- Nucleic acid therapeutics: RNA structure and interactions
- Competitors: Rosetta, molecular dynamics suites

**3. Materials science ($1B+ market)**
- Battery materials: Li-ion intercalation from quantum mechanics
- Catalysis: surface chemistry, reaction mechanisms
- Polymers: mechanical properties from first principles
- Competitors: VASP, Quantum ESPRESSO, Materials Project

**4. Academic research (growing SaaS market)**
- Teaching: interactive quantum chemistry in the browser
- Research: rapid prototyping of molecular systems
- Publications: novel results from new methodology

#### Competitive advantages

| Feature | RealQM | AlphaFold2 | Classical MD | Ab initio QM |
|---------|--------|-----------|-------------|--------------|
| Bond breaking | ✓ | ✗ | ✗ | ✓ |
| Drug binding | ✓ | ✗ | Limited | ✓ |
| Speed (1000 atoms) | Seconds/step | N/A | Milliseconds | Hours |
| Novel chemistry | ✓ | ✗ | ✗ | ✓ |
| No training data | ✓ | ✗ | ✗ | ✓ |
| Browser-based | ✓ | ✗ | ✗ | ✗ |
| Solvent effects | ✓ | ✗ | ✓ | Limited |
| Scales to proteins | ✓ | ✓ | ✓ | ✗ |

---

### Business Model

#### Phase 1: SaaS Platform (Year 1-2)

**Product**: Cloud-hosted RealQM with web interface
- Upload molecule → compute electron density → visualize in 3D
- Pre-built workflows: drug binding, protein folding, material properties
- API for integration with existing pipelines

**Pricing**:
- Free tier: small molecules (<50 atoms), 200³ grid
- Professional: $500/month, up to 500 atoms, 300³ grid, priority GPU
- Enterprise: $5,000/month, unlimited atoms, 400³+ grid, dedicated GPU, API access
- Academic: 50% discount

**Revenue target**: 100 professional + 10 enterprise customers = $1.2M ARR by end of Year 2

#### Phase 2: Pharma Partnerships (Year 2-3)

**Product**: Custom drug discovery platform
- Integrate with pharma compound libraries
- Predict binding affinity for lead compounds
- Virtual screening at quantum accuracy
- On-premise deployment option for IP-sensitive work

**Revenue**: 2-3 pharma partnerships at $1-5M each = $5-10M

#### Phase 3: Materials Platform (Year 3-4)

**Product**: Materials discovery engine
- Battery materials: Li/Na-ion intercalation
- Catalysts: reaction mechanism prediction
- Semiconductor: defect chemistry

**Revenue**: Materials companies + government contracts = $5M+

#### Phase 4: Platform Ecosystem (Year 4+)

- Marketplace for custom r_c parameters (community-contributed elements)
- Integration with lab automation (predict → synthesize → validate loop)
- Educational platform licensing to universities

---

### Technology Roadmap

#### Near-term (6 months)
- Fix proton transfer instability (steeper r_c barrier)
- Improve Poisson convergence for long-range forces
- Add elements: S, P (for DNA backbone), Fe (for heme), Zn (for zinc fingers)
- Cloud deployment on A100/H100 GPUs (400³+ grids)
- GFP (238 res) and beyond on cloud hardware

#### Medium-term (12 months)
- Dispersion force correction (DFT-D3 style, parameterized per element)
- Multi-GPU support for 500³+ grids (10,000+ atoms)
- Automated r_c fitting from experimental bond lengths
- Free energy perturbation for drug binding affinity
- Python API for scripting

#### Long-term (24 months)
- Relativistic corrections for heavy elements (Au, Pt catalysis)
- Excited states (photochemistry, fluorescence — GFP chromophore)
- Machine-learned r_c parameters from ab initio reference data
- Real-time collaborative visualization

---

### Team Requirements

- **CEO/Business**: Pharma/biotech commercialization experience
- **CTO**: WebGPU/GPU compute expert (existing founder expertise)
- **Chief Scientist**: Quantum chemistry PhD, method validation
- **Head of Pharma**: Drug discovery domain expertise, pharma relationships
- **Head of Engineering**: Cloud infrastructure, API development
- **2-3 Application Scientists**: Customer workflows, benchmarking

Initial team: 3-4 people. Grow to 10-15 by end of Year 2.

---

### Funding

#### Seed Round: $2-3M
- Cloud infrastructure (GPU instances)
- Core team (4 people, 18 months)
- First pharma pilot project
- Patent filing

#### Series A: $10-15M (at 12-18 months)
- Scale engineering team
- Pharma partnerships
- Materials platform
- Sales and marketing

#### Use of funds (Seed)
| Category | Amount | Purpose |
|----------|--------|---------|
| People | $1.5M | 4 FTE × 18 months |
| Cloud/GPU | $400K | A100 instances for development and customers |
| IP/Legal | $200K | Patents, incorporation, pharma contracts |
| Marketing | $200K | Conference presence, publications, web presence |
| Operations | $200K | Office, tools, travel |

---

### Intellectual Property

#### Core IP
1. **Domain decomposition for molecular simulation**: Each electron as independent spatial region with level-set boundary evolution
2. **Real-space pseudopotential model**: r_c parameterization for backbone atoms (C, N, O, H)
3. **Gradient-of-P force computation**: Nuclear forces from averaged potential gradient in local sphere
4. **WebGPU molecular simulation engine**: Browser-based quantum chemistry

#### Freedom to operate
- Domain decomposition QM is a novel approach distinct from DFT, HF, and post-HF methods
- No existing patents on this specific methodology
- WebGPU implementation is entirely original
- r_c parameterization is empirical (not patentable per se, but the method is)

#### Publication strategy
- Preprint on arXiv with benchmark results
- Full paper in Journal of Chemical Theory and Computation
- Application papers with pharma collaborators

---

### Risk Analysis

| Risk | Severity | Mitigation |
|------|----------|------------|
| Accuracy insufficient for drug discovery | High | Systematic validation against DFT/experiment; dispersion correction |
| GPU hardware evolves away from WebGPU | Medium | Core algorithms are hardware-agnostic; can port to CUDA/Metal |
| Competition from ML force fields | High | ML cannot handle novel chemistry; RealQM is complementary |
| Proton transfer instability limits dynamics | Medium | Active research; multiple fix strategies identified |
| Pharma adoption slow | Medium | Start with academic partnerships; publish validation studies |
| Scaling beyond 1000 atoms | Medium | Multi-GPU; cloud hardware; algorithmic improvements |

---

### Why Now

1. **WebGPU is mature**: Chrome 113+, Safari 17+, Edge 113+. Consumer GPUs have 8-16 GB memory.
2. **AlphaFold2 showed the market**: Billions invested in computational biology. But AF2 has fundamental limitations that create market demand for physics-based methods.
3. **Drug discovery needs quantum**: The "easy" drugs are found. Novel targets require understanding of electronic effects that classical force fields cannot capture.
4. **Materials crisis**: Battery, semiconductor, catalyst design needs predictive simulation beyond parameterized potentials.
5. **Cloud GPU costs dropping**: A100 instances at $1-2/hour make quantum simulation accessible.

---

### Summary

RealQM is a new kind of quantum chemistry — fast enough for proteins, accurate enough for chemistry, accessible enough for a web browser. It does what AlphaFold2 cannot: predict the behavior of molecules from physics alone, including drug binding, chemical reactions, and novel materials.

The technology is demonstrated across atoms, molecules, DNA, RNA, proteins up to 153 residues, protein-protein docking, metallic bonding, and phase transitions. All from the same quantum mechanical engine with no training data.

**Ask**: $2-3M seed round to build the team, deploy on cloud, and secure first pharma partnership.

**Vision**: Make quantum mechanics as accessible as a Google search — type in a molecule, get its physics.

---

*RealQM — Quantum mechanics, real-time, real-space, real results.*

*Contact: physicalquantummechanics.wordpress.com*
*Code: github.com/Claes542/H2O*
